Aitia, the leader in computationally discovering and applying new knowledge of biological causes of disease to pharmaceutical discovery and development, today announced a collaboration with Gustave ...

The large molecule drug substance CDMO market is anticipated to expand at a CAGR of ~9% during the forecast period. Key ...

Potential import taxes on pharma goods entering the United States continue to have effects on the industry in more ways than ...

Dr Hasan Mahmud Reza, a professor at the Department of Pharmaceutical Sciences at North South University (NSU), has been awarded the Bangladesh Academy of Sciences (BAS) Gold Medal 2024 in the Senior ...

With innovations in feedstock options and growing awareness about environmental impact, bio-wax is rapidly emerging as a ...

Discover trends shaping the pharmaceutical sector. Get insights on rising prescription drug prices, supply chains, and growth ...

For decades, pharmaceutical research has centred around developing chemical compounds to treat diseases. Scientists in lab ...

Targeting PDE4 drives anti-inflammatory and antifibrotic effects, and Boehringer has been working on its own PDE4 inhibitor ...

Under the agreement, Intragrand has granted Transpire Bio an exclusive license to develop, manufacture, and commercialize ITG-1052 in all territories except China. Terms of the agreement are not ...

Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...

Thwarted in her ambition to become a brewmaster, Kiran Mazumdar-Shaw channeled her frustrations into building a knockoff drug ...

2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), congratulates its partner CANbridge Pharmaceuticals on the ...